Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study

By Pelinck M.J.   Vogel N.E.A.   Hoek A.   Arts E.G.J.M.   Simons A.H.M.   Heineman M.J.  

Human Reproduction, Vol. 20, Iss. 3, 2005-03 ,pp. : 642-648

Oxford University Press

Access to resources Recommend Favorite

Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols

By Lossl K.   Andersen A.N.   Loft A.   Freiesleben N.L.C.   Bangsbøll S.   Andersen C.Yding  

Human Reproduction, Vol. 21, Iss. 10, 2006-10 ,pp. : 2593-2600

Oxford University Press

Access to resources Recommend Favorite

Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles

By Kolibianakis Efstratios M.   Bourgain Claire   Papanikolaou Evangelos G.   Camus Michel   Tournaye Herman   Van Steirteghem André C.   Devroey Paul  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2453-2456

Oxford University Press

Access to resources Recommend Favorite

A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

By Out Henk J.  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 90-95

Oxford University Press

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite